PhRMA v. Thompson
Executive Summary
Washington, D.C. appeals court is scheduled to hear oral arguments in the Pharmaceutical Research & Manufacturers of America's case against HHS' approval of the Healthy Maine Prescription demonstration program Dec. 5. The D.C. federal court ruled that the program qualifies for manufacturer rebates (1'The Pink Sheet" March 4, p. 13)...
Washington, D.C. appeals court is scheduled to hear oral arguments in the Pharmaceutical Research & Manufacturers of America's case against HHS' approval of the Healthy Maine Prescription demonstration program Dec. 5. The D.C. federal court ruled that the program qualifies for manufacturer rebates (1 (Also see "Maine Medicaid Waiver Qualifies For Rx Rebates By State Contributions – Court" - Pink Sheet, 4 Mar, 2002.), p. 13).... |